Home/Pipeline/Immunoglobulin Therapies

Immunoglobulin Therapies

Primary Immunodeficiencies

CommercialMarketed

Key Facts

Indication
Primary Immunodeficiencies
Phase
Commercial
Status
Marketed
Company

About CSL

CSL Limited is one of the world's largest biotechnology companies, specializing in plasma-derived therapies, vaccines, and innovative medicines. With a global presence spanning over 35 countries and employing more than 27,000 people, CSL has built a reputation for scientific excellence and operational expertise over more than a century. The company's diversified portfolio includes life-saving treatments for rare diseases, critical care medicines, and seasonal and pandemic vaccines.

View full company profile

Other Primary Immunodeficiencies Drugs

DrugCompanyPhase
Immunodeficiency TreatmentsSwedish Orphan BiovitrumCommercial